Co-Authors
This is a "connection" page, showing publications co-authored by Majid Marjani and Hamidreza Jamaati.
Connection Strength
1.469
-
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947.
Score: 0.232
-
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals. Tanaffos. 2020 Nov; 19(2):91-99.
Score: 0.228
-
A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol. Iran J Pharm Res. 2020; 19(1):31-36.
Score: 0.215
-
Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital. Tanaffos. 2018 Mar; 17(3):183-187.
Score: 0.189
-
Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727.
Score: 0.059
-
Effect of bromhexine in hospitalized patients with COVID-19. J Investig Med. 2021 Mar 15.
Score: 0.058
-
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407.
Score: 0.058
-
Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329.
Score: 0.058
-
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021 Nov-Dec; 27(6):486-492.
Score: 0.057
-
Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299.
Score: 0.057
-
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205.
Score: 0.057
-
Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128.
Score: 0.057
-
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
Score: 0.055
-
Paecilomyces formosus Infection in an Adult Patient with Undiagnosed Chronic Granulomatous Disease. J Clin Immunol. 2017 05; 37(4):342-346.
Score: 0.045
-
Usefulness of pulmonary artery diameter in diagnosing pulmonary hypertension in patients admitted to tuberculosis intensive care unit. Int J Mycobacteriol. 2016 Dec; 5 Suppl 1:S56.
Score: 0.043